These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9561064)

  • 1. T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment.
    Bulte JW; Brooks RA; Moskowitz BM; Bryant LH; Frank JA
    Acad Radiol; 1998 Apr; 5 Suppl 1():S137-40; discussion S145-6. PubMed ID: 9561064
    [No Abstract]   [Full Text] [Related]  

  • 2. Relaxometry and magnetometry of the MR contrast agent MION-46L.
    Bulte JW; Brooks RA; Moskowitz BM; Bryant LH; Frank JA
    Magn Reson Med; 1999 Aug; 42(2):379-84. PubMed ID: 10440963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NC100150 Injection, a preparation of optimized iron oxide nanoparticles for positive-contrast MR angiography.
    Kellar KE; Fujii DK; Gunther WH; Briley-Saebø K; Bjørnerud A; Spiller M; Koenig SH
    J Magn Reson Imaging; 2000 May; 11(5):488-94. PubMed ID: 10813858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging.
    Weissleder R; Lee AS; Fischman AJ; Reimer P; Shen T; Wilkinson R; Callahan RJ; Brady TJ
    Radiology; 1991 Oct; 181(1):245-9. PubMed ID: 1887040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION-46L enhanced in vivo MRI: early histopathological correlation.
    Xu S; Jordan EK; Brocke S; Bulte JW; Quigley L; Tresser N; Ostuni JL; Yang Y; McFarland HF; Frank JA
    J Neurosci Res; 1998 Jun; 52(5):549-58. PubMed ID: 9632311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents.
    Frank JA; Miller BR; Arbab AS; Zywicke HA; Jordan EK; Lewis BK; Bryant LH; Bulte JW
    Radiology; 2003 Aug; 228(2):480-7. PubMed ID: 12819345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of field strength and iron oxide nanoparticle concentration on the linearity and diagnostic accuracy of off-resonance imaging.
    Farrar CT; Dai G; Novikov M; Rosenzweig A; Weissleder R; Rosen BR; Sosnovik DE
    NMR Biomed; 2008 Jun; 21(5):453-63. PubMed ID: 17918777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages.
    Moore A; Weissleder R; Bogdanov A
    J Magn Reson Imaging; 1997; 7(6):1140-5. PubMed ID: 9400860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite.
    Gillis P; Koenig SH
    Magn Reson Med; 1987 Oct; 5(4):323-45. PubMed ID: 2824967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles.
    Koenig SH; Kellar KE
    Magn Reson Med; 1995 Aug; 34(2):227-33. PubMed ID: 7476082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetically labeled cells can be detected by MR imaging.
    Weissleder R; Cheng HC; Bogdanova A; Bogdanov A
    J Magn Reson Imaging; 1997; 7(1):258-63. PubMed ID: 9039625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical lymph node metastases: MR imaging of gadofluorine M and monocrystalline iron oxide nanoparticle-47 in a rabbit model of head and neck cancer.
    Choi SH; Han MH; Moon WK; Son KR; Won JK; Kim JH; Kwon BJ; Na DG; Weinmann HJ; Chang KH
    Radiology; 2006 Dec; 241(3):753-62. PubMed ID: 17032913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral iron oxide distribution: in vivo mapping with MR imaging.
    Zimmer C; Weissleder R; O'Connor D; LaPointe L; Brady TJ; Enochs WS
    Radiology; 1995 Aug; 196(2):521-7. PubMed ID: 7617871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton relaxation enhancement.
    Wood ML; Hardy PA
    J Magn Reson Imaging; 1993; 3(1):149-56. PubMed ID: 8428082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract.
    Lönnemark M; Hemmingsson A; Carlsten J; Ericsson A; Holtz E; Klaveness J
    Acta Radiol; 1988; 29(5):599-602. PubMed ID: 3166884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of the lymphotropic nanoparticle MRI contrast agent ferumoxtran-10.
    Islam T; Wolf G
    Cancer Biomark; 2009; 5(2):69-73. PubMed ID: 19414923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of iron oxides on proton relaxivity.
    Josephson L; Lewis J; Jacobs P; Hahn PF; Stark DD
    Magn Reson Imaging; 1988; 6(6):647-53. PubMed ID: 2850434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Superparamagnetic iron oxide particles: what value has the T1 effect in the MR diagnosis of focal liver lesions?].
    Urhahn R; Adam G; Busch N; Chen JH; Euringer W; Günther RW
    Rofo; 1996 Oct; 165(4):364-70. PubMed ID: 8963049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
    Ittrich H; Lange C; Dahnke H; Zander AR; Adam G; Nolte-Ernsting C
    Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.